Topics
April 2014 | Editor's Message
A Bittersweet Sign Off
Rachel Renshaw, Editor-in-Chief
May 27, 2026
Nanoscope Therapeutics Selects InspiroGene by McKesson to Support Distribution of Retinal Therapy
Cure Blindness Project Releases 2025 Impact Report Highlighting Global Reach and Restored Vision
May 26, 2026
Outlook Therapeutics Wins FDA Appeal for Lytenava, Plans BLA Resubmission in June
May 22, 2026
Zeiss Appoints Bronwyn Brophy O’Connor as Head of Medical Technology Segment and CEO of Carl Zeiss Meditec
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
